Seres Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
30 Sep 24 | BuyUS$15,000,001 | Nestlé S.A. | Company | 14,285,715 | US$1.05 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 922,425 | 0.608% |
Public Companies | 21,781,753 | 14.4% |
VC/PE Firms | 23,117,045 | 15.2% |
Institutions | 46,237,773 | 30.5% |
General Public | 59,671,999 | 39.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.9%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
23,117,045 | US$17.9m | 0% | 3.64% | |||
22,717,164 | US$17.6m | 0.29% | no data | |||
21,781,753 | US$16.9m | 191% | no data | |||
6,285,749 | US$4.9m | -6.67% | no data | |||
2,407,112 | US$1.9m | 165% | 0.18% | |||
1,777,601 | US$1.4m | 73% | no data | |||
1,762,157 | US$1.4m | -74.2% | no data | |||
1,427,700 | US$1.1m | 125% | no data | |||
1,133,625 | US$878.1k | -46.8% | no data | |||
1,004,978 | US$778.5k | -81.5% | 0.01% | |||
721,758 | US$559.1k | -8.02% | no data | |||
707,073 | US$547.7k | 718% | no data | |||
607,510 | US$470.6k | -40.5% | no data | |||
525,947 | US$407.4k | -29.6% | no data | |||
418,208 | US$323.9k | -69.9% | 0.02% | |||
340,761 | US$264.0k | 0% | 0.84% | |||
339,548 | US$263.0k | -82.6% | no data | |||
314,177 | US$243.4k | 0% | no data | |||
292,300 | US$226.4k | 0% | 0.07% | |||
267,398 | US$207.1k | -10.3% | no data | |||
215,388 | US$166.8k | 0% | no data | |||
200,726 | US$155.5k | 89.4% | no data | |||
187,800 | US$145.5k | 0% | 0.01% | |||
182,442 | US$141.3k | 0% | no data | |||
164,649 | US$127.5k | -64.6% | no data |